Medical Device News Magazine

Health at Scale Awarded Patent for Breakthrough AI Technology for Smart Hyper-Personalized Provider Navigation

Awarded patent by USPTO for technology innovations in AI-guided provider search for primary and specialist care to optimize PCP assignment and drive smart specialist referrals

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Health at Scale, the market leader in smart AI-powered technologies to optimize care management, announced today that it has been awarded a patent by the U.S. Patent and Trademark Office for its breakthrough advances in personalized patient-provider matching using machine learning.

Choosing a provider is often the most important decision a patient makes. Health at Scale’s patented technology transforms provider search by empowering patients to find optimal primary and specialist care provider matches specific to their unique individualized health conditions and needs. This represents a significant advancement over current navigation technologies that consider providers in isolation of the patient – and are typically based on ad-hoc reputation scores or process-based metrics that are not correlated with better outcomes.

Health at Scale’s invention uses new AI technologies to score patient-provider matches based on thousands of health factors about a patient and an understanding of which providers have historically done well with similar kinds of patients. This proprietary approach, offering smart hyper-personalized provider navigation to payers, employers, providers and patients, evaluates the best facility, practice and physician choices for each individual’s unique health situation, and enables the creation of deeply personalized networks for the N-of-1. Health at Scale’s novel approach uses advanced machine learning to simultaneously construct and relate information across multiple models that evaluate the best providers for each individual based on a vast number of factors related to the patient, provider, the time and setting.

This patent advances Health at Scale’s mission to re-invent care delivery as a precise and personalized process that is deeply aware of each patient’s unique health characteristics and circumstances at all times. By rethinking the patient-provider matching process, Health at Scale drives improved outcomes, costs, satisfaction, quality and equity, while reducing unnecessary waste and cost in the system.

“Putting each patient’s needs at the center of care management is a core element of our work at Health at Scale. We’re excited to lead the way in reimagining the how patients find providers: as a process that is built around each patient and shows a nuanced understanding and deep empathy for their unique needs in the moment,” said Zeeshan Syed, Health at Scale CEO and formerly a Clinical Associate Professor at Stanford Medicine and an Associate Professor with Tenure in Computer Science at the University of Michigan. “We’re proud of the recognition from the USPTO for our team’s thought-leadership and pioneering contributions in personalized navigation and are committed to continued innovation for the populations we serve.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”